<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>23(1)</volume><submitter>Bawa Z</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Medicinal cannabis (MC) products have been available on prescription in Australia for around six years. General practitioners (GPs) are at the forefront of MC prescribing and recent years have seen substantial increases in prescription numbers. This study examined the current knowledge, experiences, and attitudes of Australian GPs around MC. We also compared our findings to those of an earlier 2017 investigation.&lt;h4>Method&lt;/h4>We conducted a cross-sectional study using a 42-item on-line questionnaire adapted from our earlier 2017 survey. The current survey was completed by GPs attending an on-line, multi-topic educational seminar. Australian GPs (n = 505) completed the survey between November 2021 and February 2022. Data were synthesised using descriptive statistics. MC </pubmed_abstract><journal>BMC primary care</journal><pagination>330</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9760535</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Knowledge, experiences, and attitudes of Australian General Practitioners towards medicinal cannabis: a 2021-2022 survey.</pubmed_title><pmcid>PMC9760535</pmcid><pubmed_authors>McCartney D</pubmed_authors><pubmed_authors>Manocha R</pubmed_authors><pubmed_authors>Bawa Z</pubmed_authors><pubmed_authors>McGregor IS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Knowledge, experiences, and attitudes of Australian General Practitioners towards medicinal cannabis: a 2021-2022 survey.</name><description>&lt;h4>Background&lt;/h4>Medicinal cannabis (MC) products have been available on prescription in Australia for around six years. General practitioners (GPs) are at the forefront of MC prescribing and recent years have seen substantial increases in prescription numbers. This study examined the current knowledge, experiences, and attitudes of Australian GPs around MC. We also compared our findings to those of an earlier 2017 investigation.&lt;h4>Method&lt;/h4>We conducted a cross-sectional study using a 42-item on-line questionnaire adapted from our earlier 2017 survey. The current survey was completed by GPs attending an on-line, multi-topic educational seminar. Australian GPs (n = 505) completed the survey between November 2021 and February 2022. Data were synthesised using descriptive statistics. MC </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2025-07-24T03:04:26.682Z</modification><creation>2025-02-19T01:56:03.095Z</creation></dates><accession>S-EPMC9760535</accession><cross_references><pubmed>36529730</pubmed><doi>10.1186/s12875-022-01946-x</doi></cross_references></HashMap>